Veterinary Medicines

RILEXINE 200, intramaminė suspensija galvijams

Authorised
  • Cefalexin monohydrate
Download as PDF

Product identification

Medicine name:
RILEXINE 200, intramaminė suspensija galvijams
Active substance:
  • Cefalexin monohydrate
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cefalexin monohydrate
    200.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Meat and offal
        4
        day
      • Milk
        2
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51DA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Haupt Pharma Latina S.r.l.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/04/1635/001
Date of authorisation status change:

Documents

RV1635.pdf

Lithuanian (PDF)
Published on: 28/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."